Literature DB >> 19019355

Risk factors for surgically removed fibroids in a large cohort of teachers.

Claire Templeman1, Sarah F Marshall2, Christina A Clarke3, Katherine DeLellis Henderson4, Joan Largent2, Susan Neuhausen2, Peggy Reynolds3, Giske Ursin5, Leslie Bernstein4.   

Abstract

OBJECTIVE: To describe reproductive and lifestyle correlates of surgically confirmed fibroids.
DESIGN: Prospective cohort study.
SETTING: The California Teachers Study, an ongoing prospective study of more than 133,000 female teachers and school administrators identified through the California State Teachers Retirement System. PATIENT(S): California Teachers Study cohort members, reporting no previous history of fibroids, were ascertained prospectively for surgical diagnosis of fibroids using hospital patient discharge records. MAIN OUTCOME MEASURE(S): Multivariable Cox proportional hazards regression methods were used to assess the association of self-reported menstrual, reproductive, and lifestyle characteristics with fibroids, using ages at the start and end of follow-up (in months) to define time on study. Hazard rate ratios, presented as relative risks (RR) with 95% confidence intervals (CI), were estimated. RESULT(S): The strongest risk factor we identified was African-American race/ethnicity, as compared to non-Latina white women. We observed a reduced risk of fibroids for postmenopausal women in comparison to premenopausal women, but use of hormone replacement therapies (regardless of formulation) were associated with an increased risk. Other risk factors included race, a family history of fibroids, being overweight, and drinking alcohol, Smoking and diabetes were associated with a decreased risk of fibroids. CONCLUSION(S): These observations provide a more detailed epidemiologic profile of women with surgically managed fibroids.

Entities:  

Mesh:

Year:  2008        PMID: 19019355      PMCID: PMC2765807          DOI: 10.1016/j.fertnstert.2008.08.074

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  38 in total

1.  Risk factors for uterine leiomyoma: a practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking.

Authors:  E Faerstein; M Szklo; N Rosenshein
Journal:  Am J Epidemiol       Date:  2001-01-01       Impact factor: 4.897

Review 2.  Epidemiology of uterine leiomyomata.

Authors:  S M Schwartz
Journal:  Clin Obstet Gynecol       Date:  2001-06       Impact factor: 2.190

3.  Residential proximity to agricultural pesticide use and incidence of breast cancer in the California Teachers Study cohort.

Authors:  Peggy Reynolds; Susan E Hurley; Debbie E Goldberg; Sauda Yerabati; Robert B Gunier; Andrew Hertz; Hoda Anton-Culver; Leslie Bernstein; Dennis Deapen; Pamela L Horn-Ross; David Peel; Richard Pinder; R K Ronald K Ross; Dee West; William E Wright; Argyrios Ziogas
Journal:  Environ Res       Date:  2004-10       Impact factor: 6.498

4.  Age at menarche and estrogen concentrations of adult women.

Authors:  L Bernstein; M C Pike; R K Ross; B E Henderson
Journal:  Cancer Causes Control       Date:  1991-07       Impact factor: 2.506

5.  Growth dynamics of human leiomyoma cells and inhibitory effects of the peroxisome proliferator-activated receptor-gamma ligand, pioglitazone.

Authors:  C J Loy; S Evelyn; F K Lim; M H Liu; E L Yong
Journal:  Mol Hum Reprod       Date:  2005-07-28       Impact factor: 4.025

6.  Variation in the incidence of uterine leiomyoma among premenopausal women by age and race.

Authors:  L M Marshall; D Spiegelman; R L Barbieri; M B Goldman; J E Manson; G A Colditz; W C Willett; D J Hunter
Journal:  Obstet Gynecol       Date:  1997-12       Impact factor: 7.661

7.  Alcohol consumption and total estradiol in premenopausal women.

Authors:  P Muti; M Trevisan; A Micheli; V Krogh; G Bolelli; R Sciajno; H J Schünemann; F Berrino
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-03       Impact factor: 4.254

8.  Validating California teachers study self-reports of recent hospitalization: comparison with California hospital discharge data.

Authors:  Sarah F Marshall; Dennis Deapen; Mark Allen; Hoda Anton-Culver; Leslie Bernstein; Pamela L Horn-Ross; David Peel; Rich Pinder; Peggy Reynolds; Ronald K Ross; Dee West; Al Ziogas
Journal:  Am J Epidemiol       Date:  2003-11-15       Impact factor: 4.897

9.  Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot.

Authors:  C P West; M A Lumsden; S Lawson; J Williamson; D T Baird
Journal:  Fertil Steril       Date:  1987-07       Impact factor: 7.329

10.  Postmenopausal estrogen and progestogen therapy and the risk of uterine leiomyomas.

Authors:  Susan D Reed; Kara L Cushing-Haugen; Janet R Daling; Delia Scholes; Stephen M Schwartz
Journal:  Menopause       Date:  2004 Mar-Apr       Impact factor: 2.953

View more
  47 in total

1.  Study of Environment Lifestyle and Fibroids (SELF): Advancing the Field of Fibroid Epidemiology.

Authors:  Lauren A Wise
Journal:  J Womens Health (Larchmt)       Date:  2015-09-29       Impact factor: 2.681

2.  Cardiovascular risk factors and diseases in women undergoing hysterectomy with ovarian conservation.

Authors:  Shannon K Laughlin-Tommaso; Zaraq Khan; Amy L Weaver; Cathy D Schleck; Walter A Rocca; Elizabeth A Stewart
Journal:  Menopause       Date:  2016-02       Impact factor: 2.953

3.  Increased urinary cobalt and whole blood concentrations of cadmium and lead in women with uterine leiomyomata: Findings from the ENDO Study.

Authors:  Erica B Johnstone; Germaine M Buck Louis; Patrick J Parsons; Amy J Steuerwald; Christopher D Palmer; Zhen Chen; Liping Sun; Ahmad O Hammoud; Jessie Dorais; C Matthew Peterson
Journal:  Reprod Toxicol       Date:  2014-06-30       Impact factor: 3.143

4.  Lower prevalence of non-cavity-distorting uterine fibroids in patients with polycystic ovary syndrome than in those with unexplained infertility.

Authors:  Hao Huang; Hongying Kuang; Fangbai Sun; Michael P Diamond; Richard S Legro; Christos Coutifaris; Ruben Alvero; Randal D Robinson; Peter R Casson; Gregory M Christman; Karl R Hansen; Nanette Santoro; Esther Eisenberg; Heping Zhang
Journal:  Fertil Steril       Date:  2019-03-27       Impact factor: 7.329

Review 5.  Racial and ethnic disparities in benign gynecologic conditions and associated surgeries.

Authors:  Vanessa L Jacoby; Victor Y Fujimoto; Linda C Giudice; Miriam Kuppermann; A Eugene Washington
Journal:  Am J Obstet Gynecol       Date:  2010-04-28       Impact factor: 8.661

6.  The study of MED12 gene mutations in uterine leiomyomas from Iranian patients.

Authors:  Samaneh Sadeghi; Mandana Khorrami; Mona Amin-Beidokhti; Maryam Abbasi; Zeeba Kamalian; Shiva Irani; Mirdavood Omrani; Ozra Azmoodeh; Reza Mirfakhraie
Journal:  Tumour Biol       Date:  2015-08-23

7.  Air pollution and risk of uterine leiomyomata.

Authors:  Shruthi Mahalingaiah; Jaime E Hart; Francine Laden; Kathryn L Terry; Renée Boynton-Jarrett; Ann Aschengrau; Stacey A Missmer
Journal:  Epidemiology       Date:  2014-09       Impact factor: 4.822

8.  Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma.

Authors:  Andrew S Brohl; Li Li; Vaagn Andikyan; Sarah G Običan; Angela Cioffi; Ke Hao; Joel T Dudley; Charles Ascher-Walsh; Andrew Kasarskis; Robert G Maki
Journal:  Oncologist       Date:  2015-03-12

9.  Environmental tobacco smoke and risk of late-diagnosis incident fibroids in the Study of Women's Health across the Nation (SWAN).

Authors:  Jason Y Y Wong; Po-Yin Chang; Ellen B Gold; Wesley O Johnson; Jennifer S Lee
Journal:  Fertil Steril       Date:  2016-07-18       Impact factor: 7.329

10.  Ensuring long-term sustainability of existing cohorts remains the highest priority to inform cancer prevention and control.

Authors:  Graham A Colditz
Journal:  Cancer Causes Control       Date:  2010-01-09       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.